About Aaron Fletcher
Form D filings for ONL Therapeutics in 2024 list Aaron Fletcher as director.
Aaron Fletcher first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Aaron Fletcher in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Aaron Fletcher works with at each company, as listed on that company's latest Form D.
ONL Therapeutics, Inc. · Form D, Sep 16, 2024
DE
David Esposito
CEO & President, director
CC
Constance Chang
Executive officer
MS
Michal Silverberg
Director
BB
Bill Burns
Director
DZ
David Zacks
Executive officer
MN
Marian Nakada
Director